Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Threshold power levels for NPe6 photodynamic therapy.

Kazi AA, Peyman GA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi D, Moshfeghi AA.

Ophthalmic Surg Lasers. 2000 Mar-Apr;31(2):136-42.

PMID:
10743925
2.

Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).

Mori K, Yoneya S, Ohta M, Sano A, Anzai K, Peyman GA, Moshfeghi DM.

Ophthalmology. 1999 Jul;106(7):1384-91.

PMID:
10406627
3.

Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.

Mori K, Yoneya S, Anzail K, Kabasawa S, Sodeyama T, Peyman GA, Moshfeghi DM.

Retina. 2001;21(5):499-508.

PMID:
11642380
4.

Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels.

Peyman GA, Kazi AA, Moshfeghi D, Unal M, Khoobehi B, Yoneya S, Mori K, Rivera I.

Ophthalmic Surg Lasers. 2000 Jul-Aug;31(4):323-7.

PMID:
10928670
5.

Evaluation of the new photosensitizer Tookad (WST09) for photodynamic vessel occlusion of the choroidal tissue in rabbits.

Framme C, Sachs HG, Flucke B, Theisen-Kunde D, Birngruber R.

Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5437-46.

PMID:
17122134
6.

Problems with and pitfalls of photodynamic therapy.

Peyman GA, Kazi AA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi DM.

Ophthalmology. 2000 Jan;107(1):29-35.

PMID:
10647715
7.

PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion.

Obana A, Gohto Y, Kaneda K, Nakajima S, Miki T.

Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2639-45.

PMID:
11581211
8.

Selective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10.

Obana A, Gohto Y, Kaneda K, Nakajima S, Takemura T, Miki T.

Lasers Surg Med. 1999;24(3):209-22.

PMID:
10229152
9.

Retreatment effect of NPe6 photodynamic therapy on the normal primate macula.

Nakashizuka T, Mori K, Hayashi N, Anzail K, Kanail K, Yoneya S, Moshfeghi DM, Peyman GA.

Retina. 2001;21(5):493-8.

PMID:
11642379
10.

Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodynamic therapy: time dependencies.

Moshfeghi DM, Peyman GA, Moshfeghi AA, Khoobehi B, Primbs GB, Crean DH.

Ophthalmic Surg Lasers. 1998 Aug;29(8):663-8.

PMID:
9715492
12.

Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2).

Peyman GA, Moshfeghi DM, Moshfeghi A, Khoobehi B, Doiron DR, Primbs GB, Crean DH.

Ophthalmic Surg Lasers. 1997 May;28(5):409-17.

PMID:
9150524
13.

Choriocapillaris photodynamic therapy using indocyanine green.

Costa RA, Farah ME, Freym├╝ller E, Morales PH, Smith R, Cardillo JA.

Am J Ophthalmol. 2001 Oct;132(4):557-65.

PMID:
11589879
14.

[Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].

Mori K, Ohta M, Sano A, Yoneya S, Sonoda M, Kaneda A, Sato Y.

Nippon Ganka Gakkai Zasshi. 1997 Feb;101(2):134-40. Japanese.

PMID:
9124093
15.

Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.

Nagae T, Aizawa K, Uchimura N, Tani D, Abe M, Fujishima K, Wilson SE, Ishimaru S.

Lasers Surg Med. 2001;28(4):381-8.

PMID:
11344521
16.

Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.

Berdugo M, Bejjani RA, Valamanesh F, Savoldelli M, Jeanny JC, Blanc D, Ficheux H, Scherz A, Salomon Y, BenEzra D, Behar-Cohen F.

Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1633-44. doi: 10.1167/iovs.07-0767.

PMID:
18385085
17.

Fluorescence properties of a hydrophilic sensitizer in pigmented rats, rabbits, and monkeys.

Moshfeghi D, Peyman GA, Kazi AA, Unal M, Khoobehi B, Yoneya S, Mori K.

Ophthalmic Surg Lasers. 1999 Nov-Dec;30(9):750-3.

PMID:
10574497
18.

Selective photodynamic effects of the new photosensitizer ATX-S10(Na) on choroidal neovascularization in monkeys.

Obana A, Gohto Y, Kanai M, Nakajima S, Kaneda K, Miki T.

Arch Ophthalmol. 2000 May;118(5):650-8.

PMID:
10815157
19.

Lutetium texaphyrin (Lu-Tex): a potential new agent for ocular fundus angiography and photodynamic therapy.

Blumenkranz MS, Woodburn KW, Qing F, Verdooner S, Kessel D, Miller R.

Am J Ophthalmol. 2000 Mar;129(3):353-62.

PMID:
10704552
20.

Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.

Kikuchi T, Asakura T, Aihara H, Shiraki M, Takagi S, Kinouchi Y, Aizawa K, Shimosegawa T.

Anticancer Res. 2003 Nov-Dec;23(6C):4897-900.

PMID:
14981942

Supplemental Content

Support Center